Andromeda Metals (ADN) Q4 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 TU earnings summary
5 Oct, 2025Executive summary
Advanced project funding for Great White Project, securing $75 million debt facility credit approval and progressing additional funding with select capital providers.
Achieved successful validation of Great White CRM™ as a high-quality kaolin product for industrial glazes, opening new sales opportunities in the ceramics industry.
Produced high purity alumina (HPA) at 99.9985% purity using a novel flowsheet, with independent validation, supporting future product portfolio expansion.
Raised approximately $5 million through a share placement to institutional and sophisticated investors.
Financial highlights
Cash and cash equivalents at quarter end were $7.142 million, up from $4.668 million in the previous quarter.
Net funds used in operating activities were $1.458 million; net funds used in investing activities were $672,000; net funds from financing activities were $4.604 million.
Exploration and evaluation expenditure during the quarter was $650,000.
Estimated quarters of funding available is 3.42 based on current cash and outgoings.
Outlook and guidance
Finalisation and execution of the $75 million debt facility are contingent on securing the balance of project funding.
Scoping Study for the HPA Project underway to assess market opportunities, with ongoing product development and marketing activities.
Continued focus on advancing the Great White Project and expanding the kaolin and HPA product portfolio.
Latest events from Andromeda Metals
- Construction-ready kaolin project advances with secured offtakes and narrowed net loss.ADN
H2 202426 Mar 2026 - Significant impairment and funding needs led to a $101.6 million net loss despite capital raised.ADN
H1 202620 Mar 2026 - Shovel-ready kaolin project advances with strong economics, secured offtakes, and active funding efforts.ADN
Investor Update20 Jan 2026 - AGM confirmed strong project economics, secured offtakes, and advancing funding and development.ADN
AGM 202520 Nov 2025 - Advancing two high-value mineral projects with secured funding, offtakes, and strong market outlook.ADN
Noosa Mining Investor Conference18 Nov 2025 - Secured major funding, advanced HPA project, and raised $13M to support ongoing development.ADN
Q1 2026 TU30 Oct 2025 - Advancing a de-risked kaolin project and innovative HPA venture with robust market outlook.ADN
Investor Presentation16 Oct 2025 - Net loss narrowed 45% as funding and offtake deals advanced the Great White Project.ADN
H1 20257 Oct 2025 - GWP advanced with secured offtakes, improved loss, and strong HPA project economics.ADN
H2 20255 Oct 2025